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Abstract
Background: Evidence about relevant outcomes is required in the evaluation of clinical interventions for children with
autism spectrum disorders (ASD). However, to date, the variety of outcome measurement tools being used, and lack of
knowledge about the measurement properties of some, compromise conclusions regarding the most effective
interventions.
Objectives: This two-stage systematic review aimed to identify the tools used in studies evaluating interventions for anxiety
for high-functioning children with ASD in middle childhood, and then to evaluate the tools for their appropriateness and
measurement properties.
Methods: Electronic databases including Medline, PsychInfo, Embase, and the Cochrane database and registers were
searched for anxiety intervention studies for children with ASD in middle childhood. Articles examining the measurement
properties of the tools used were then searched for using a methodological filter in PubMed, and the quality of the papers
evaluated using the COSMIN checklist.
Results: Ten intervention studies were identified in which six tools measuring anxiety and one of overall symptom change
were used as primary outcomes. One further tool was included as it is recommended for standard use in UK children’s
mental health services. Sixty three articles on the properties of the tools were evaluated for the quality of evidence, and the
quality of the measurement properties of each tool was summarised.
Conclusions: Overall three questionnaires were found robust in their measurement properties, the Spence Children’s
Anxiety Scale, its revised version – the Revised Children’s Anxiety and Depression Scale, and also the Screen for Child
Anxiety Related Emotional Disorders. Crucially the articles on measurement properties provided almost no evidence on
responsiveness to change, nor on the validity of use of the tools for evaluation of interventions for children with ASD.
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Introduction
The choice of relevant outcomes, and of robust tools to
measure those, is a vital stage in the design of evaluation of
clinical interventions for children. Where tools are reliable and
valid, and outcomes important to children and families, the
findings can inform parents, clinicians, researchers, service
providers and policy makers about which interventions are most
effective. However, to date the outcome measures used for
intervention trials for children with autism spectrum disorder
(ASD) are too varied to allow sensible decisions about what
interventions might be most effective [1;2].
Meta-analyses can increase the power of findings by pooling
data from individual studies. For example, a meta-analysis of the
Revised Children’s Manifest Anxiety Scale across 43 studies has
found evidence of validity and responsiveness to treatment [3].
Cross-study syntheses of outcome evidence such as this are much
needed in the field of ASD, because individual trials are in the
main very small and include broad age groups [4;5]. There have
been discussions of these problems and suggestions of which
outcome measures to use [6;7], but no widespread uptake in ASD
studies.
The focus of the current review is on how to choose appropriate
and robust tools to measure outcomes of interventions for a
common problem encountered by high-functioning children with
ASD – how to cope with symptoms of anxiety in the period of
middle childhood. With around 40 per cent having symptoms at
the severity of an anxiety disorder [8], and the prevalence of ASD
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being around 1 per cent [9], this is an important public health
problem. In the UK, a government initiative titled ‘Increasing
Access to Psychological Therapies’ (IAPT) [10] has since 2012
been extended to children’s mental health services, with cognitive
behaviour therapy (CBT) for problems such as anxiety and
depression as one of the core strands. Outcome monitoring is
embedded in the programme.
It is important to have a choice of reliable measurement tools
for a particular health condition in order to capture relevant
outcomes, and different points of view including patient reported
outcomes [11]. A choice of measurement tools also facilitates
answering a range of research questions, tailored to the objectives
of the intervention, ideally meeting the needs of particular
developmental stages [12], and allowing different tools to be used
for study outcome evaluation and for selection criteria [13].
Without choice of appropriate tools the benefits of an intervention
may be missed or inflated [11;14].
In this systematic review, the tools used to measure outcomes
in evaluations of clinical interventions for anxiety in children
with high-functioning ASD in middle childhood are identified
and their quality assessed. Middle childhood is defined here as 8
to 14 years of age during which time children will be entering
puberty, beginning some level of personal independence from
their parents, and experiencing transition between primary and
secondary school. We focus on high-functioning ASD as the
children are likely to be able to participate in verbally-loaded
interventions such as CBT, even although the prevalence of
comorbid psychiatric conditions is similar across IQ and levels of
adaptive behaviour [15]. This systematic review will facilitate
recommendations of robust tools for use in anxiety intervention
trials for children with high-functioning ASD in middle
childhood.
The review was conducted in two stages. In stage 1,
identification of tools was done by systematic search for literature
describing studies of treatment interventions for anxiety in ASD in
middle childhood. Then in stage 2, searches focused on the tools
used to measure primary outcomes, and articles about these tools
were examined for evidence of appropriateness and measurement
properties.
Review Methods: Stage 1
The review protocol was registered online with the International
Prospective Register of Systematic Reviews (Registration number:
CRD42012002684) and can be accessed at (http://www.crd.york.
ac.uk/PROSPERO/prospero.asp). The protocol also pertains to
social skills interventions, though only the anxiety interventions
and outcome tools are reported here. Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) standards
are followed in this report (see Checklist S1).
Search Strategy
The following electronic bibliographic databases were searched:
MEDLINE, EMBASE, ERIC, PsycINFO, The Cochrane Library
(Cochrane Database of Systematic Reviews, Cochrane Central
Register of Controlled Trials (CENTRAL), and Cochrane
Methodology Register). The search strategy included the terms
shown in Table 1 which were combined using database-specific
filters, where these were available. The search was restricted to
articles in English, and those published between 1992 and
February 2013, the date when the last searches were run. The
term Asperger Syndrome was first included as a separate diagnosis
in the WHO International Classification of Diseases in 1992 [16]
so we expected separate identification of groups of children with
ability in the average range to be more frequent and consistent in
studies after this date.
Selection Criteria
Anxiety was clinically defined as in the International Classifi-
cation of Diseases [16] and the Diagnostic and Statistical Manual
of Mental Disorders [17]. The interventions included cognitive
and behavioural approaches, and excluded drug trials, physiolog-
ical interventions (e.g. biofeedback) and purely physical interven-
tions (e.g. massage). Intervention studies where a broad range of
skills were the target (e.g. social skills, or drama classes) were
excluded. The interventions included were ameliorative, preven-
tative or educational, aimed at managing and regulating emotional
reactions which may be precursors to anxiety disorder.
Studies were included when over 50% of participants were aged
8 to 14 years old, or the mean age of the ASD sample was within
Table 1. Stage 1 review search terms.
1. (ASC or ASD or Asperg$ or Autis$ or high functioning or communicat$ or Kanner$ or language delay$ or pervasive developmental disorder$ or language disorder$
or HFA or autistic disorder or child development disorders).tiab
2. (child$ or school$ or pediatric$ or paediatric$ or special needs or teenage$ or adolescent$ or youth$).tiab
3. (behavio$ or intervent$ or program$ or rehabilit$ or therap$ or train$ or treat$ or verbal or cognitive behavio$ therapy or CBT or pervasive therapy or outcome
assessment or treatment outcome).tiab
4. (worr$ or stress$ or phobi$ or anxiety or phobic disorders).tiab
5. randomi#ed controlled trial.tiab
6. random$.tiab
7. comparative stud$.tw
8. prospective stud$.tw
9. treatment effectiveness evaluation/
10. intervention$.tiab
11. 5 or 6 or 7 or 8 or 9 or 10
12. 1 and 2 and 3 and 4 and 11
13. limit 12 to English language; 1992 – current; age 8 to 14 years
doi:10.1371/journal.pone.0085268.t001
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this range, so that measures were likely to be appropriate across
the target age range for the review. Where child participants had a
range of differing diagnoses, the study was included if ASD
outcome data were presented separately, and if half or more of
participants have ASD.
Group studies with designs including before-and-after, con-
trolled trials, quasi-experimental, and randomised controlled trials
(RCT) were included. Studies which used only observational
methods of recording outcomes (e.g. event recording) were
excluded. The review was restricted to articles published in English.
One reviewer (SW) screened the titles and abstracts of articles;
where there was doubt whether an article met the inclusion criteria
it was included. Full text sifting was by one reviewer (SW); any
ambiguous papers were discussed with the second reviewer (HM)
to reach consensus. The references of the selected articles were
searched.
Data extraction
Data extraction was performed by one reviewer (SW) using a
previously tested data extraction form. The following information
was noted: participant characteristics, focus of intervention,
outcome tools used, domains captured, and by whom the tool
was reported/measured.
Results: Stage 1
The searches retrieved 750 articles from which 10 articles were
retained [18–27]. See Figure 1 for search strategy flow diagram.
Nine articles report on seven RCTs of adapted CBT for anxiety
delivered to high-functioning children with ASD in middle
childhood. These studies varied in sample size from 22 to 71
participants, used varied approaches and materials, and included
from 6 group sessions [26] to 16 group [23] or individual sessions
[19–21]. The before-and-after study included 6 participants in 16
group sessions of CBT [25]. All but two [23;25] included training
for parents. Taken together the studies provide encouraging
evidence that CBT can be efficacious for children with ASD and
anxiety disorder.
Seven different primary outcome tools were used in these
studies. The Anxiety Disorders Interview Schedule (ADIS) [28] is
a clinician-administered interview. Five are parent and self-report
child anxiety questionnaires [29–33]. One further tool is a
clinician or researcher rating of overall improvement, the Clinical
Global Impressions – Improvement (CGI-I) [34]. No intervention
studies meeting our inclusion criteria used the Revised Children’s
Anxiety and Depression Scale (RCADS) [35]; however as it is an
IAPT recommended outcome tool it was also included in stage 2
(Table 2). None of the tools was developed specifically for children
with ASD. All of the tools were developed in English (though at
stage 2 some articles evaluating the measurement properties of the
SCARED were on revised versions developed in Dutch).
Review Methods: Stage 2
In order to assess the measurement properties of the tools, a
comprehensive search was conducted using a methodological
Figure 1. Search strategy flow diagram at Stage 1.
doi:10.1371/journal.pone.0085268.g001
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search filter designed to locate articles on measurement properties
in PubMed [36].
Data extraction method
Once identified, the methodological quality of each article was
examined using the COSMIN checklist (COnsensus based
Standards for the selection of health based Measurement
INstruments). The checklist considers 9 properties of measure-
ment, each with multiple items rated on a 4 point scale: internal
consistency, reliability, measurement error, content validity,
structural validity, hypothesis testing, criterion validity, respon-
siveness to change (and cross-cultural validity, not considered in
the present review). For each article, the properties addressed are
given an overall rating of excellent, good, fair, poor based on the
lowest item rating awarded [37]. The checklists were completed by
one reviewer (SW) with frequent discussion of ratings with a
second reviewer (HM) to reach consensus. To check reliability the
second reviewer independently rated 10% of the articles using the
checklist. Agreement on final rating of each property was 71.5%.
Evidence Synthesis
The quantitative findings in each study were then given a
quality rating of positive, indeterminate or negative for each
measurement property examined [38]. For example, internal
consistency is considered positive where Cronbach’s alpha is equal
to or greater than 0.70; criterion validity is considered positive
where there are convincing arguments that the gold standard is
‘gold’ and correlation is equal to or greater than 0.70.
Finally the quality ratings for the findings were considered in
conjunction with the quality rating for the level of evidence in the
articles about each tool [38]. This synthesis records strong evidence
(+++ or 222) where several methodologically good articles, or
one excellent article, find consistent evidence for or against a
measurement property; moderate evidence (++ or 22) for several
methodologically fair, or one good study; a rating of limited (+ or2)
for one study of fair quality; and otherwise a rating of conflicting
evidence (+/2) or unknown (?) evidence [38].
Results: Stage 2
The search in PubMed produced 1096 articles from which 63
were retained for data extraction (Figure 2). The study population
characteristics for these articles are shown in Table 3.
Only four articles assessing measurement properties included an
ASD sample, reporting on use of five of the tools (i.e. not RCADS,
RCMAS or CGI). The majority of the studies were carried out in
the USA. The methodological quality of each article is presented
in Table 4. None of the articles had looked at measurement error,
so this property is not included in the table. Only one article
reported responsiveness to change. The synthesised evidence on
the quality of the measurement properties of the individual tools is
shown in Table 5. To aid interpretability [39], it is important to
have evidence on differences in scores between subgroups
(including normative data) and this was available in many of the
articles; however, no article reported on levels of minimal
important change, nor on floor and ceiling effects.
The ADIS is a clinical interview, with entry-level questions
which determine which areas of anxiety disorder are explored.
The recommended procedure is that parent and child are
interviewed separately, and then the interviewer determines the
disorder diagnoses and clinical severity rating. When the separate
interviews are compared, agreement is low both at the level of
whether a disorder is indicated and at symptom level (though one
study [42] found the latter to be higher). As a clinical interview,
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some measurement properties such as internal consistency and
content validity have not been studied, with the latter presumably
assumed because the measure was developed from the Diagnostic
and Statistical Manual of Mental Disorders [17]. In many studies
ADIS is used as the ‘gold standard’ against which questionnaire
measures are compared. Its strengths lie in inter-rater reliability,
and evidence also of test-retest reliability.
Turning to the questionnaire measures, evidence for internal
consistency of the parent and child versions of the SCAS was
strong for total and subscale scores, apart from the fear of physical
injuries subscale [33;40;94;95] and generalised anxiety disorder
(GAD) subscale [40]. Test-retest reliability for child report was
r = .60 [33] at 6 months, and r = .63 at 3 months [94] which seems
acceptable (the COSMIN criterion of r$0.80 may be set unduly
high for a subjective measure of feelings).
Evidence for the structural validity of the six factor structure for
the SCAS child version was strong [33;91;94], though lower for
the parent version the confirmatory factor analysis finding only
acceptable evidence of fit [98] (root mean square error of
approximation (RMSEA) = .075) [92]. Criterion validity of the
SCAS was supported by significantly higher scores in a clinical
than a non-clinical group [33;92;95], more than 80% of those with
an anxiety disorder correctly classified, and discrimination
between disorders good apart from GAD and panic-agoraphobia
[92]. Convergent and divergent validity were demonstrated by
significantly higher correlations between the child report SCAS
and RCMAS than with the Child Depression Inventory (CDI)
[33;94]; and furthermore by significantly higher correlations
between SCAS parent and the Child Behavior Checklist (CBCL)
internalising than externalising scales [92], and higher between
SCAS child and the Strengths and Difficulties Questionnaire
emotional subscale than with the conduct or hyperactivity
subscales [91].
Findings for parent-child agreement for the SCAS depended on
the analysis conducted. Using ANOVA, it was found that parents
rated significantly higher than children on all subscales apart from
OCD and panic-agoraphobia [93]. In contrast, studies reporting
correlations [40;95;96] consistently found r..50 on total and
subscale scores, apart from on GAD [40].
The RCADS was developed as a revision of the SCAS, in order
to correspond to dimensions of several DSM-IV anxiety disorders
and also to include major depression. In particular, it was intended
to refine the measurement of GAD to reflect core aspects of
‘worry’. Internal consistency was found to be good for subscales,
and also for the shortened Anxiety 15 item version. In the original
study [35] one week test-retest reliability ranged from r= .65 to
.80. The total variance explained by the factor analysis was less
than 50%; however, subsequent confirmatory factor analyses have
reported good fit to the 6 factor solution [52;62;66] for the child
scale, and acceptable for the parent scale [63;64]. Convergent and
divergent validity have been shown convincingly, as has criterion
validity with diagnoses based on standardised clinical psychiatric
interview.
The MASC has well-established strengths in internal consisten-
cy (except for the subscale Harm Avoidance in [55]) and in test-
retest reliability. The latter has been shown at 3 weeks [56;57] and
Figure 2. Search strategy flow diagram at Stage 2.
doi:10.1371/journal.pone.0085268.g002
Outcome Measures of Anxiety in ASD
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e85268
Table 3. Characteristics of study populations in articles on measurement properties.
Measure Article Ref No.
Study
Population/sample
Mean age (SD)
years; range N
Male %
(child) Country
ADIS Brown-Jacobsen
et al (2011)
40 Anxiety diagnostic
clinic
12.32(3.3); 7–18 88 55.7 USA
Canavera et al (2009) 41 OCD 12.17 (X); 6–17 93 46.2 USA
Comer & Kendal (2004) 42 Anxiety disorder clinic 10.2 (1.8); 7.5–14 98 54 USA
Grills & Ollendick (2003) 43 Psychology clinic 10.69 (2.66); X 165 63.6 USA
Higa-McMillan (2008) 44 CBT centre 12.3 (3.3); 6–18.2 289 68.2 Hawaii
Lyneham et al (2007) 45 Anxiety disorder clinic 11.25 (2.58); 7–16 153 50.3 Australia
Lyneham & Rapee (2005) 46 Anxiety clinic
and community
9.2 (1.9); 6–12 73 67 Australia
Silverman et al (2001) 47 Psychosocial
research centre
10.15 (X); 7–16 62 39.6 USA
Storch et al (2012) 48 ASD 10.34 (2.21); 7–17 85 76.5 USA
Wood et al (2002) 49 Anxiety disorder clinic 11.71 (2.64); 8–17 186 53.8 USA
MASC Anderson et al (2009) 50 School 14.5 (X); 13–17 372 45.7 USA
Baldwin & Dadds (2007) 51 Community 11.36 (1.21); 9.16–14.42 452 46 Australia
Brown et al (2012)* 52 Paediatric primary
care clinic
12.3 (2.7); 7–17 229 36.6 USA
Dierker et al (2001) 53 School 14 (X); 13–15 632 45 USA
Grills-Taquechel
et al (2008)
54 Mixed clinical
diagnoses
10.44 (2.64); 7–17 262 65 USA
Langer et al (2010) 55 Anxiety clinic 11.61 (2.64); 6–17 174 54 USA
March et al (1997) 56 Clinical 11.6 (X); 8–16 (M) 24 75 USA
11.8 (X); 8–16 (F)
School 12.9 (2.23); 8–17 (M) 374 48.6
13.17 (2.35); 8–17 (F)
March et al (1999) 57 School 13.98 (2.6); 8–18 142 35 USA
Ross et al (2007) 58 Asthma 14.66 (1.75); 12–18 53 50.9 Canada
Rynn et al (2006) 59 Anxiety disorder 12.2 (3.3); X 116 57.8 USA
Depression 13.5 (3.1) 77 48.1
Thaler et al (2010) 60 Learning disability 13.75 (1.81); 11–17 41 78.6 USA
White et al (2012) 61 HFASD 14.58 (1.67); 12–17 30 76.67 USA
Wood et al (2002) 49 Outpatient
anxiety clinic
11.71 (2.64); 8–17 186 53.8 USA
RCADS Brown et al (2012)* 52 Pediatric primary
care clinic
sample
12.13 (2.7); 7–17 229 36.6 USA
Chorpita et al (2000) 35 Schools 12.87 (2.82); 6.17–18.92 1641 45.6 Hawaii
Chorpita et al (2005) 62 Clinical (CBT centre) 12.9 (2.7); 7.5–17.9 513 67.4 Hawaii
Ebesutani et al (2010) 63 Clinical (CBT centre) 11.5 (2.5); 6.55–18.97 490 67.8 Hawaii
Ebesutani et al (2011) 64 School 13.3 (2.98); 8–18 967 45.1 Hawaii
Ebesutani et al (2012) 65 School 10.3 (1.7); 7–14 1060 39.3 Hawaii
Clinic 303 67.3
Trent et al (2012) 66 School Grades 2 to 12 12 659 49 USA
RCMAS Cole et al (2000) 67 School 11.9 (0.5); 10.7–13.5 562 (T1) 49 USA
630 (T2)
Dadds et al (1998) 68 School X (X); 7–14 1786 40.9 Australia
Dierker et al (2001) 53 School 14 (X); 13–15 632 45 USA
Kenny & Faust (1997) 69 Mental health centre 10 (2.87); 5–16 54 64.9 USA
Nelson & Renzenbrink
(1995)
70 Psychiatric hospital 14.28 (1.57); 12–17 25 36 USA
Olatunji & Cole (2009) 71 School 8.96 (0.61); 8–12 787 48 USA
Outcome Measures of Anxiety in ASD
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e85268
Table 3. Cont.
Measure Article Ref No.
Study
Population/sample
Mean age (SD)
years; range N
Male %
(child) Country
Paget & Reynolds (1984) 72 Learning disability 12.8 (1.2) 6–17 106 68.9 USA
Perrin & Last (1992) 73 Clinic and
community
X (X); 5–17 213 100 USA
Pina et al (2009) 74 Anxiety clinic 10.21 (2.78); 6–16 677 52.7 USA
Reynolds & Paget
(1981)
75 School X (X); 6–19 4972 50.2 USA
Reynolds & Richmond
(1997)
30 School X (X); 6–18 (group 1) 329 X USA
X (X); 7–17 (group 2) 167
White & Farrell (2001)* 76 School 11.6 (0.6); 10.8–14.1 898 X USA
Wisniewski et al (1987) 77 School 12.1(0.92); 11–14 161 45 USA
SCARED Bailey et al (2006) 78 Pediatric Primary care 14.54 (1.27); 8–17 190 51 USA
Birmaher et al (1997) 31 Mood/anxiety
disorders
outpatient clinic
14.5 (2.3); 9–18 341 41 USA
Birmaher et al (1999) 79 Mood/anxiety
disorders clinic
13.8 (2.5); 9–19 190 C 48 USA
166 P
Bodden et al (2009) 80 Clinically anxious 12.5 (2.7); 8–18 138 40 Netherlands
Gen pop control 12.4(2.6) 8–18 38 37
Gonzalez et al (2012)** 81 Drawn from
families seeking
outpatient
mental health services
13.96 (1.89); 11–18 374 C 53.9 USA
10.69 (3.57); 5–18 808 P 62.3
Jastrowski et al (2012) 82 Pediatric chronic
pain clinic
14.21 (2.54); 8–18 349 31 USA
Monga et al (2000) 83 Mood/anxiety
disorders outpatient
clinic
14.4 (2.3); 9–18.9 295 43 USA
Muris and Steerneman
(2001)
84 Anxiety disorder
or disruptive
disorder
12.8 (2.4); 8–17 48 54.2 Netherlands
Muris et al (1999) 85 School 12.2 (0.5); 11–14 101 47 Netherlands
9.6 (1.1); 8–12 71 50.1
10 (1.2); 8–12 88 61.2
Muris et al (2004) 86 Anxiety outpatient 12 (2.9); 7–17 242 57.9 Netherlands
Muris & Mayer
et al (2001)
87 Clinically anxious 9.9 (1.4); 8–13 36 25 Netherlands
Simon & Bogels
(2009)
88 School High anxious 9.92 (1.23); 8–13 188 45 Netherlands
Median anxious 10.22 (1.13); 8–13 82 54
Van Steensel (2012) 89 ASD and anxiety
disorder
11.37 (X); 7–18 115 78.3 Netherlands
Anxiety disorder 12.79; 7–18 122 50.8
Wren et al (2007) 90 Pediatric Primary care 10.5 (1.4); 8–13 515 49.1 USA
SCAS Brown-Jacobsen et al (2011) 40 Clinically anxious 12.32 (3.3);7–18 88 55.7 USA
Essua et al (2011)*** 91 General population 14.44 (1.7); 12–17 469 46.5 England
Nauta et al (2004) 92 Clinically anxious;
general population
10.8 (2.4); 6–18 745 52 Australia;
Netherlands
Russell & Sofronoff
(2005)
93 AS; clinically
anxious and
normative data
X (X); 10–13 65 (AS) 84.6 Australia
Spence (1998) 33 General population;
clinical (separation
and social phobia)
10.11 (1.25); 8–12 2052 42 Australia
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3 months [56]; indeed [60] have shown stability estimates around
r = 0.50 for child-report and higher (.56 to .70) for parent-report in
a community sample. The original factor analysis [56] for the
MASC explained only 39.4% of the total variance; however,
subsequent confirmatory factor analyses have found good fit for
the four factor solution [51;52;54] though one study [59] found
only acceptable evidence of fit (e.g. RMSEA =0.73) [98].
Correlations with other measures of anxiety are high, with
discriminant validity established (usually by lower agreement with
scales measuring depression). Findings for criterion validity have
been variable, showing high levels of agreement with diagnostic
groupings (diagnostic interview or ADIS as ‘gold standard’) in
some community [50;54] and clinical studies [59;60;49– except for
generalised anxiety disorder], but not in other clinical studies
[55;58] and in the school-based study by Dierker and colleagues
[53] where generalised anxiety disorder was well predicted in girls,
but social phobia and specific phobia were not. As for ADIS and
SCARED (below), agreement between child and parent report was
low [51;60;61]; In the MASC source paper [56] mother-child
agreement was only r = .39, and father-child and father-mother
agreement were negligible.
Articles generally report high internal consistency of the
RCMAS but often do not give figures for the subscales. Only
one study reported test-retest reliability, which was high (one week
r = .88; five week r = .77). One study hypothesised stability of
scores for psychiatric inpatients over a 4 week period, but instead
found reduction in anxiety not substantiated by clinical rating
[70]. Both content validity and structural validity appear strong.
The latter has been examined in a number of ways, with several
studies considering congruence of factors and their relationships
across parent/child or different ethnic groups. However, one small
study of children with learning disability [72] reported a lower
proportion of variance accounted for by the general anxiety factor
than was found in the normative sample. Some RCMAS articles
suggested convergent and divergent validity, but the better quality
studies found less convincing results. The one study to compare
RCMAS child report with parent (parents completed the Revised
Behavior Problem Checklist) found significant disagreement [69].
The two studies of criterion validity against diagnostic interview
produced conflicting results; the clinic study supported criterion
validity [73] but the community study concluded that the RCMAS
was less successful than the MASC in identifying anxiety and
depression [53].
There are a number of versions of the SCARED. The original
38 and 41 item tools have good content validity being derived
from DSM [31], some evidence of test-retest reliability for total
and subscale scores on both parent and child versions [31], plus
consistently good internal reliability. Good structural validity was
found [82] though evidence for measurement invariance was not
as strong (RMSEA ..06) [81]. Criterion validity was good
[78;81]: clinically anxious children scored significantly higher on
the child SCARED than non-anxious, depressed and disruptive
groups on total and subscale scores [79;83], and by examining
area under the curve (AUC) against clinical interview [78;83].
The SCARED-Revised is a 66 item measure with nine
subscales. Internal consistency was found to be good though the
quality of the articles varied. The total scores and most of the
subscales had good internal consistency, except OCD (parent and
child versions), blood/injection/injury (child) and environmental/
situational (parent) [85] and specific phobias [84]. Test-retest
reliability of the child total score was positive (r..80) with the
subscales approaching this level apart from GAD, separation,
OCD and traumatic stress (r,.70) [85]. Correlations across time
with the State Trait Anxiety Inventory for Children demonstrated
responsiveness to change though the quality of the evidence was
limited [87]. Significantly higher SCARED-R scores were
predictive of those with anxiety disorders, demonstrating criterion
validity, though the GAD, specific phobias and separation anxiety
subscales performed less well in the child version [86]. Correla-
tions between parent and child were mixed with both high [86]
and low [85] agreement found.
The SCARED-71 is a version adding five further social phobia
items to the SCARED-R. Internal consistency was positive in
parent and child versions for total and all but one subscale scores
(OCD, child report) [89]. Criterion validity in terms of predict-
ability of diagnosis by corresponding subscale was good except for
Table 3. Cont.
Measure Article Ref No.
Study
Population/sample
Mean age (SD)
years; range N
Male %
(child) Country
Spence (2003) 94 General population 13.51 (0.51); 13–14 875 54 Australia
Whiteside & Brown
(2008)
95 Community 12.74 (2.35); 9–18 85 55 USA
Anxiety disorders 13.21 (2.81); 9–18 85 55
Whiteside et al (2012) 96 Community 10.42 (1.5); 8–13 420 49 USA
Anxiety disorders 12.81 (3.1); 7–18 196 52
SWQ Bailey et al (2006) 78 Primary care 14.5 (1.27); 8–17 190 51 USA
Russell & Sofronoff
(2005)
93 AS; clinically
anxious and
normative data
X (X); 10–13 65 (AS) 84.6 Australia
CGI Lewin et al (2012) 97 OCD 12.2 (2.5); X 71 36.6 USA
ADIS: Anxiety Disorders Interview Schedule. MASC: Manifest Anxiety Scale for Children. RCADS: Revised Child Anxiety and Depression Scale. RCMAS: Revised Child
Manifest Anxiety Scale. SCARED: Screen for Child Anxiety and Related Emotional Disorders. SCAS: Spence Children’s Anxiety Scale. SWQ: Social Worries Questionnaire.
CGI: Clinical Global Impressions.
X = No details. M = male; F = female. C: child; P: parent. AS: Asperger Syndrome. ASD: autism spectrum disorder. CBT: cognitive behaviour therapy. HFASD: high-
functioning ASD. OCD: obsessive-compulsive disorder. T1 = Time 1; T2 = Time 2.
*looked at cross ethnic validity (all participants African American); ** looked at cross ethnic validity (all participants African American or non Hispanic white); *** Data
collected from 5 European countries – details are for UK sample.
doi:10.1371/journal.pone.0085268.t003
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Table 4. Methodological quality of each article per measurement property and instrument according to COSMIN Checklist.
Measure Article
Ref
No. Version
Internal
Consistency Reliability
Content
Validity
Structural
Validity
Hypothesis
Testing
Criterion
Validity Responsiveness
ADIS Brown-Jacobsen
et al (2011)
40 C + P - - - - Good - -
Canavera et al
(2009)
41 C + P - - - - Good - -
Comer & Kendal
(2004)
42 C + P - Good - - Good - -
Grills & Ollendick
(2003)
43 C + P - Good - - Good - -
Higa-McMillan
(2008)
44 C - - - good - - -
Lyneham et al
(2007)
45 C + P - good - - - - -
Lyneham &
Rapee (2005)
46 C + P - good - - - - -
Silverman et al
(2001)
47 C + P - good - - good - -
Storch et al
(2012)
48 C + P - - - - good - -
Wood et al
(2002)
49 C + P - - - - good - -
MASC Anderson et al
(2009)*
50 C good - - - excellent excellent -
Baldwin &
Dadds (2007)
51 C + P excellent - - excellent good - -
Brown et al
(2012)
52 C good - - good - - -
Dierker et al
(2001)
53 C fair - - - - good -
Grills-Taquechel
et al (2008)
54 C excellent - - good - excellent -
Langer et al
(2010)
55 C + P fair - - - - good -
March et al
(1997)
56 C + P excellent poor a - excellent poor a - -
March &
Sullivan (1999)
57 C - good - - - - -
Ross et al
(2007)
58 C - - - - - good -
Rynn et al
(2006)
59 C good - - good good excellent -
Thaler et al
(2010)
60 C + P fair - - - fair fair -
White et al
(2012)
61 C + P fair - - - fair - -
Wood et al
(2002)
49 C + P - - - - - excellent -
RCADS Brown et al
(2012)
52 C good - - good - - -
Chorpita et al
(2000)
35 C excellent good good excellent good - -
Chorpita et al
(2005)
62 C excellent - - excellent fair excellent -
Ebesutani et al
(2010)
63 P excellent - - excellent good excellent -
Ebesutani et al
(2011)
64 P excellent good - excellent excellent - -
Ebesutani et al
(2012)
65 C Short excellent - - excellent - excellent -
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Table 4. Cont.
Measure Article
Ref
No. Version
Internal
Consistency Reliability
Content
Validity
Structural
Validity
Hypothesis
Testing
Criterion
Validity Responsiveness
Trent et al
(2012)
66 C excellent - - excellent - - -
RCMAS Cole et al
(2000)**
67 C + P poor b - - excellent - - -
Dadds et al
(1998)***
68 C good - - - good - -
Dierker et al
(2001)
53 C fair - - - good good -
Kenny & Faust
(1997)
69 C - - - - good - -
Nelson &
Renzenbrink
(1995)
70 C - poor - - poor a - -
Olatunji & Cole**
(2009)
71 C good excellent - excellent - - -
Paget & Reynolds
(1984)
72 C poor b - - poor a - - -
Perrin & Last
(1992)
73 C - - - - - fair -
Pina et al (2009) 74 C - - - excellent fair - -
Reynolds & Paget
(1981)
75 C - - - excellent - - -
Reynolds &
Richmond (1997)
30 C poor - fair - fair - -
White & Farrell
(2001)
76 C - - excellent excellent - - -
Wisniewski et al
(1987)
77 C - good - - - - -
SCARED Bailey et al
(2006)*
78 C + P - - - - - excellent -
Birmaher et al
(1997)
31 C + P excellent fair good good fair excellent -
Birmaher et al
(1999)
79 C + P poor a - - poor a fair fair -
Bodden et al
(2009)
80 C + P
SCARED-71
good - - - - excellent -
Gonzalez et al
(2012)
81 C + P good - - excellent - excellent (P) -
Jastrowski et al
(2012)
82 C + P excellent - - excellent good - -
Monga et al
(2000)
83 C + P - - - - excellent excellent -
Muris et al
(1999)
85 C + P
SCARED-R
good good - - good - -
Muris et al
(2004)
86 C + P
SCARED-R
poor - - - fair excellent -
Muris & Mayer et
al (2001)
87 C SCARED-
R
- - - - - fair fair
Muris and
Steerneman (2001)
84 C SCARED-
R
fair - - - fair fair -
Simon & Bogels
(2009)
88 C SCARED-
71
- - - - - excellent -
Van Steensel
(2012)
89 C + P
SCARED-71
good - - - good excellent -
Wren et al
(2007)
90 C + P - - - excellent good - -
SCAS Brown-Jacobsen et al
(2011)
40 C + P good - - - good good -
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GAD [88]. However, correlations with ADIS parent report were
low, for both anxiety disorder and ASD groups [89].
The parent version of the Social Worries Questionnaire has
good evidence of criterion validity with agreement for social
phobia (AUC ..80) as measured by the ADIS [78]. Parent reports
on the SWQ also demonstrated that children with Asperger
syndrome were significantly more anxious than typically develop-
ing children, on a par with a clinically anxious sample. As
predicted by Russell and Sofronoff, parent and child reports of
anxiety differed [93].
The CGI-I showed inter-rater agreement for parent-child,
therapist-parent, therapist-child, and independent evaluator-
parent though most of the correlations were ,.70. Across time,
improvement was reported significantly sooner by parents and
children than by therapists and the independent evaluator,
though judgements tended to converge by 14 weeks of treatment
for OCD.
Discussion
Principal Findings
In this systematic review, eight tools were found which had been
used to measure primary outcomes in anxiety intervention trials
for children with high-functioning ASD in middle childhood. A
second systematic search of literature found sixty-three articles
studying children and examining the measurement properties of
the eight tools.
There was limited or no evidence for three of the eight
properties of measurement tools rated in this review using the
COSMIN checklist: measurement error, content validity and
responsiveness to change. In terms of the primary purpose of the
review – to inform the choice of tool to measure outcomes of
intervention trials for anxiety in children with ASD – these are
serious limitations in the evidence.
Only four articles included children with ASD, and none of
these considered content validity. Indeed, the field is hampered by
lack of a definitive conceptualisation of anxiety in ASD, and the
means to capture features of anxiety as a clinical disorder separate
from ASD [15;99–102]. Anxiety interacts with core symptoms
(such as poor social skills and repetitive thoughts) and so differs in
several ways from anxiety seen in typically developing children.
For example, a child with ASD who is reluctant to go to school is
more likely to be experiencing social anxiety rather than
separation anxiety. However, until basic psychometric work
including content analysis is carried out, outcome measures
developed with typically developing children will continue to be
utilised with children with ASD [100;101].
The lack of evidence about responsiveness to change of tools is
also a limitation for the purpose of the review. The CGI
Improvement rating explicitly focuses on change, and was
utilised by three of the ASD intervention studies, indicating
treatment effects. It has been used widely in autism medication
trials [6], has comparable effect sizes to other rating scales in
adult anxiety intervention trials [103], and has the advantage
that it can be rated blind to group and time point. Therefore it is
likely to continue to be used in intervention trials for children,
even though evidence for its measurement properties was sparse
in this review.
One further property included in the COSMIN checklist was
not included in the review, cross-cultural validity. However
support for the measurement properties of the SCARED across
Table 4. Cont.
Measure Article
Ref
No. Version
Internal
Consistency Reliability
Content
Validity
Structural
Validity
Hypothesis
Testing
Criterion
Validity Responsiveness
Essua (2011) 91 C excellent - - excellent good - -
Nauta (2004) 92 P excellent - - excellent good excellent -
Russell &
Sofronoff (2005)
93 C + P - - - - good - -
Spence (1998) 33 C excellent good - excellent good excellent -
Spence et al
(2003)
94 C excellent good - excellent good - -
Whiteside &
Brown (2008)
95 C + P good - - - good good -
Whiteside et al
(2012)****
96 C + P good - - - good good -
SWQ Bailey et al
(2006)
78 P - - - - - excellent -
Russell &
Sofronoff (2005)
93 C + P - - - - good - -
CGI Lewin et al
(2012)
97 Improvement - good - - - -
-
ADIS: Anxiety Disorders Interview Schedule. MASC: Manifest Anxiety Scale for Children. RCADS: Revised Child Anxiety and Depression Scale. RCMAS: Revised Child
Manifest Anxiety Scale. SCARED: Screen for Child Anxiety and Related Emotional Disorders. SCAS: Spence Children’s Anxiety Scale. SWQ: Social Worries Questionnaire.
CGI: Clinical Global Impressions.
Measurement Error was not evaluated in any article; Cross cultural validity was not included in the review..
C = child self report; P = parent report. R = Revised.
*looked at particular subscale (Social Anxiety/Social Phobia); ** created continuous data by altering response format; *** looked at particular subscale (total score and
lie); **** looked at particular subscale (OCD).
a small sample; b no alpha for subscales.
doi:10.1371/journal.pone.0085268.t004
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several countries and cultures has been found in a meta analysis
[104] and by Gonzalez and colleagues [81].
Overall the findings of the review suggest that the tools which
are most robust in their measurement properties are the Spence
Children’s Anxiety Scale, its revised version – the Revised
Children’s Anxiety and Depression Scale, and also the Screen for
Child Anxiety Related Emotional Disorders. The weakness of the
measurement of GAD by the SCAS appears to have been
improved in the RCADS. However, self-report and parent report
generally have the limitation in RCTs of therapy that they are
not ‘blinded’. In the four ASD intervention trials which used
ADIS, participants were asked not to unblind the researcher as
they described current events and behaviours in the clinical
interview. Thus a combination of ways of measuring anxiety
(feelings and behaviours) appears to be necessary to achieve
robust measurement.
Clinical Implications
The review found a mixed picture in terms of the level of
correlation between parent and child report. Agreement is not
necessarily to be expected, with each individual reflecting different
symptoms captured (for example, more observable behaviours
being identified by the parent), and the possible influence of factors
such as the parent’s own experiences affecting sensitivity to the
child’s symptoms [105]. While the level of agreement between
parents and their children with ASD may actually be higher than
observed for typically developing groups [106], a number of
researchers [e.g. 26;61;93] comment that children with high
functioning ASD are likely to under-report anxiety symptoms, one
reason being difficulty in identifying their own (and others’)
emotions. Therefore a combination of perspectives is likely to give
a more rounded picture.
One further issue for the measurement of outcomes in
intervention trials and clinical practice in ASD is a need to
consider further what constitutes a successful outcome [13].
Necessarily, the tools reviewed here as primary outcomes focus
on clinical symptoms; however, the goals of intervention are
likely to include broader constructs such as participation and
quality of life. The International Classification of Functioning,
Disability and Health paradigm [107], which is the World
Health Organisation recommended conceptual model for mea-
suring health and disability and evaluating interventions,
emphasizes that body functions, activity and participation may
all be important indicators of intervention success. Children with
ASD may have hypersensitivity to visual and auditory stimuli,
which in turn may result in activity limitations (e.g. social
anxiety) and restricted social participation (e.g. reluctance to go
to new places). Effective interventions for anxiety would also
expect to see change in socially valid outcomes for children such
as new experiences and greater success in friendships, whatever
the nature of the baseline anxiety.
Limitations
This systematic review had some limitations. Articles were
accessed only in English as we lacked resources for translation.
Data extraction was done only in part by two independent
reviewers. Although the COSMIN manual and checklist is
validated and well structured, there is still an element of
subjectivity in the review process such that different decisions
regarding ratings and synthesis might be made by other
reviewers.
The focus was on children in middle childhood who are high-
functioning, and anxiety measurement issues in other age and
ability groups have not been considered. Nevertheless, children
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with ASD are reported to be vulnerable to high anxiety across
ages [8;108] and abilities [8;108;109] and so intervention and
measurement issues require wider examination.
Conclusions
Though there appears to be a certain international practice
consensus developing in research groups undertaking trials of
intervention for anxiety in children with ASD, the evidence for
the measurement properties of the chosen tools is patchy. The
review has allowed some conclusions to be drawn on what may
be the psychometrically sound assessment tools. However, there
requires to be further consideration of how to achieve blinded
outcome measurement in RCTs, and how to judge the
appropriateness of tools developed to measure anxiety in typically
developing children when applied with children who have ASD.
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